medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2020, Número 1

<< Anterior Siguiente >>

Acta Ortop Mex 2020; 34 (1)


Epidemiología, resultados clínicos y tasa de éxito en cirugía preservadora de cadera en la necrosis avascular de cabeza femoral

Pinilla-Gracia C, Hernández-Fernández A, Rodríguez-Nogué L, Martínez-Aznar C, Bejarano-Lasunción C, Martín-Hernández C

Idioma: Español
Referencias bibliográficas: 40
Paginas: 16-21
Archivo PDF: 180.97 Kb.


RESUMEN

Introducción: La necrosis avascular de cabeza femoral (NACF) es una patología frecuente que en sus inicios es asintomática y se manifiesta de forma insidiosa, por lo que a menudo el diagnóstico se realiza en estadios avanzados, donde la única solución eficaz es la artroplastía total de cadera (ATC). El diagnóstico en fases precoces permitirá utilizar opciones terapéuticas que eviten o retrasen la ATC. Nuestro objetivo es valorar los resultados demográficos, clínicos y la tasa de éxito en nuestro centro de pacientes con diagnóstico de NACF y que han sido subsidiarios de cirugía de preservación de cadera. Material y métodos: Estudio clínico unicéntrico, prospectivo, no controlado de pacientes con diagnóstico de NACF entre Enero de 2012 y Septiembre de 2017 con un estadio Steinberg ≤ IIIA. La técnica quirúrgica utilizada es el forage descompresivo, asociado a relleno con aloinjerto y aspirado de médula ósea. Resultados: Se intervinieron 26 caderas con nuestra técnica quirúrgica. La tasa de éxito obtenida es de 61.54%, ya que 10 casos han precisado ATC durante el estudio (38.46%). Conclusión: El éxito terapéutico en la NACF está directamente relacionado con el grado de la enfermedad, por lo que es importante el diagnóstico precoz. El forage descompresivo con relleno de aloinjerto que asocia aspirado de médula ósea es una opción a tener en cuenta, ya que en estadios iniciales muestra una elevada tasa de éxito.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014; 22: 455-64.

  2. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, et al. Osteonecrosis of the hip: Management in the 21st century. Instr Course Lect. 2003; 52: 337-55 .

  3. Petrigliano FA, Lieberman JR. Osteonecrosis of the hip: Novel approaches to evaluation and treatment. Clin Orthop Relat Res. 2007; 465(465): 53-62.

  4. Guerado E, Caso E. The physiopathology of avascular necrosis of the femoral head: an update. Injury. 2016; 47(Suppl 6): S16-S26.

  5. Gou WL, Lu Q, Wang X, Wang Y, Peng J, Lu SB. Key pathway to prevent the collapse of femoral head in osteonecrosis. Eur Rev Med Pharmacol Sci. 2015; 19(15): 2766-74.

  6. Pouya F, Kerachian MA. Avascular necrosis of the femoralhead: are any genes involved? Arch Bone Jt Surg. 2015; 3(3): 149-55.

  7. Ficat RP. Treatment of avascular necrosis of the femoral head. Hip. 1983: 279-95.

  8. Liu F, Wang W, Yang L, Wang B, Wang J, Chai W, et al. An epidemiological study of etiology and clinical characteristics in patients with nontraumatic osteonecrosis of the femoral head. J Res Med Sci. 2017; 22: 15.

  9. Larson E, Jones LC, Goodman SB, Koo KH, Cui Q. Early stage osteonecrosis of the femoral head: where are we and where are we going in year 2018? Int Orthop. Int Orthop. 2018; 42(7): 1723-8.

  10. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg (Br). 1985; 67: 3-9.

  11. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg (Br). 1995; 77: 34-41.

  12. Hong YC, Zhong HM, Lin T, Shi JB. Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis. Int J Clin Exp Med. 2015; 8(4): 5207-16.

  13. Hong YC, Luo RB, Lin T, Zhong HM, Shi JB. Efficacy of alendronate for preventing collapse of femoral head in adult patients with nontraumatic osteonecrosis. Biomed Res Int. 2014; 2014 (1), 716538.

  14. Uzun G, Mutluoglu M, Ersen O, Yildiz S. Hyperbaric oxygen therapy in the treatment of osteonecrosis of the femoral head: a review of the current literature. Undersea Hyperb Med. 2016; 43(3): 189-99.

  15. Lee JY, Kwon JW, Park JS, Han K, Shin WJ, Lee JG, et al. Osteonecrosis of femoral head treated with extracorporeal shock wave therapy: analysis of short-term clinical outcomes of treatment with radiologic staging. Hip Pelvis. 2015; 27(4): 250-7.

  16. Al-Jabri T, Tan JY, Tong GY, Shenoy R, Kayani B, Parratt T, et al. The role of electrical stimulation in the management of avascular necrosis of the femoral head in adults: a systematic review. BMC Muscoskel Disord. 2017; 18(1): 319.

  17. Hungerford DS. Response: the role of core descompression in the treatment of ischemic necrosis of the femoral head. Arthritis Rheum. 1989; 32(6): 801-6.

  18. Tooke SM, Nugent PJ, Bassett LW, Nottingham P, Mirra J, Jinnah R. Results of core decompression for femoral head osteonecrosis. Clin Orthop Relat Res. 1988; (228): 99-104.

  19. Warner JJ, Philip JH, Brodsky GL, Thornhill TS. Studies of nontraumatic osteonecrosis. The role of core decompression in the treatment of nontraumatic osteonecrosis of the femoral head. Clin Orthop Relat Res. 1987; (225): 104-27 .

  20. Specchiulli F, Capocasale N, Laforgia R, Solarino GB. The surgical treatment of idiopathic osteonecrosis of the femoral head. Ital J Orthop Traumatol. 1987; 13(3): 345-51.

  21. Chotivichit A, Korwutthikulrangsri E, Pornrattanamaneewong C, Achawakulthep C. Core decompression with bone marrow injection for the treatment of femoral head osteonecrosis. J Med Assoc Thai. 2014; 97(Suppl 9): S139-43.

  22. Saito S, Ohzono K, Ono K. Joint-preserving operations for idiopathic avascular necrosis of the femoral head. Results of core decompression, grafting and osteotomy. J Bone Jt Surg Br. 1988; 70(1): 78-84.

  23. Joint Surgery Group of the Orthopaedic Branch of the Chinese Medical Association. Guideline for Diagnostic and Treatment of Osteonecrosis of the Femoral Head. Orthop Surg. 2015; 7(3): 200-7.

  24. Wei M, Wang ZG, Liu YJ, Li ZL. Drilling decompression for femoral head necrosis at collapse stage. Zhongguo Gu Shang. 2015; 28(6): 562-6.

  25. Chotivichit A, Korwutthikulrangsri E, Auewarakul C, Sarirasririd S. Core decompression and concentrated autologous bone marrow injection for treatment of osteonecrosis of the femoral head. J Med Assoc Thai. 2012; 95(Suppl 9): S14-20.

  26. Liu F, Wang W, Yang L, Wang B, Wang J, Chai W, et al. An epidemiological study of etiology and clinical characteristics in patients with nontraumatic osteonecrosis of the femoral head. J Res Med Sci. 2017; 22: 15.

  27. De Sautu de Borbón EC, Morales CM, Guerra VJ. Prevalencia de los factores de riesgo para el desarrollo de necrosis avascular de cadera en un Hospital de Tercer Nivel. Reumatología Clínica. 2018; 14(2): 122-3.

  28. Chughtai M, Piuzzi NS, Khlopas A, Jones LC, Goodman SB, Mont MA. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Joint J. 2017; 99(10): 1267-79.

  29. Zhao D, Zhang Y, Wang W, Liu Y, Li Z, Wang B, et al. Tantalum rod implantation and vascularized iliac grafting for osteonecrosis of the femoral head. Orthopedics. 2013; 36: 789-95.

  30. Fontecha CG, Roca I, Barber I, Menendez ME, Collado D, Mascarenhas VV, et al. Femoral head bone viability after free vascularized fibular grafting for osteonecrosis: SPECT/CT study. Microsurgery. 2016; 36: 573-7.

  31. Hernigou P, Trousselier M, Roubineau F, Bouthors C, Chevallier N, Rouard H, et al. Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress. Clin Orthop Surg. 2016; 8: 1-8.

  32. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bonemarrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg. 2005; 87: 896-902.

  33. Yan Z, Hang D, Guo C, Chen Z. Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res. 2009; 27: 442-6.

  34. Tabatabaee R, Saberi S, Parvizi J, Mortazavi S, Farzan M. Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplast. 2015; 30(Suppl 1): 11-5.

  35. Ma Y, Wang T, Liao J, Gu H, Lin X, Jiang Q, et al. Efficacy of autologous bonemarrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther. 2014; 5: 115.

  36. Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012; 50: 325-30.

  37. Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplast. 2012; 27: 679-86.

  38. Pepke W, Kasten P, Beckmann N, Janicki P, Egermann M. Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: a randomized prospective study. Orthop Rev (Pavia). 2016; 8: 6162.

  39. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011; 49: 1005-9.

  40. Wang C, Wand Y, Meng HY, Yuan XL, Xu XL, Wang AI, et al. Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head. Int J Clin Exp Med. 2015; 8: 3127-35.




2020     |     www.medigraphic.com